This yearly competition supports meritorious projects, which have the potential to significantly impact the science of radiation medicine and improve patient outcome. Two $50,000 grants are awarded yearly.
The next application deadline is December 10, 2021 at 5:00 p.m. EST. Complete applications should be assembled as a single pdf and sent to Tanya.Webb@utoronto.ca.
This grant is awarded to UTDRO faculty members at the five affiliated cancer centres:
One competition is held every year and two seed-grants of $50,000 are awarded in each competition. Applications from all areas and disciplines of radiation medicine are encouraged. The grants may be used to support the direct costs of research, including supplies, salaries (but not UTDRO faculty salaries) and equipment associatedwith the proposed work.
The following projects have been successfully funded by the UTDRO Seed Grant.
Caroline Chung (PM)
May Tsao (OCC)
Jason Wong (Stronach)
The Toronto Brief Neurocognitive Battery (BNB) Development of a novel brief telephone battery for neurocognitive assessment of patients with brain metastases
Tom Purdie (PM)
Mark Ruschin (OCC)
Beibei Zhang (Stronach)
Prospective Collection of Tolerance Outcomes in Women receiving Breast Cancer Radiotherapy: A Multi-Institutional Initiative
A large group of the faculty is engaged in a number of comprehensive research programs ranging from the basic laboratory radiation research, through a rich translational research programs focused on linking laboratory with the clinic and the translation of the advances in technology to the clinic.
A full clinical research program that includes clinical trials complement these efforts and is supplemented by a growing population based research initiatives.
Activities are focused on the influence of tumour microenvironment and molecular genetics on tumour responses and outcome. There is extensive collaboration between the Department and the Departments of Medical Biophysics, Laboratory Medicine and Pathology.
The major programs are focused on:
The most well-established programs are:
Medical Physics research at PMH and OCC is in the general area of image guided precision radiation therapy. There is strong collaboration between medical physicists, radiation therapists, and radiation oncologists within the department.
Several novel technology-based clinical programs and clinical trials have been established including:
At PMH, technology research is driven by Dr. David Jaffray, one of Canada’s Top 40 under 40 for 2004, and one of the top 10 Best of the Best in Medical Imaging.
Clinical research is the principal type of research undertaken by the Department. Current clinical research activities are primarily site-based, although they can also be grouped under the general thematic areas of combined modality, fractionation, quality of life, organ preservation, tumour staging etc.
Clinical trials are conducted in:
Health services research activities have continued to grow. Several faculty members are cross appointed to the Institute of Clinical Evaluative Sciences (ICES) or the Department of Health Policy, Management & Evaluation including Drs. Bezjak, Hodgson, Paszat, Rakovitch, Wong, Ringash and Wiljer.
Examples of health services research are:
The emphasis of current research is on the evaluation of residents and faculty, faculty development, and distance education for radiation therapists.
Our two primary teaching hospitals – Odette Cancer Centre (OCC) and The Princess Margaret (PM) – rank among the largest and most progressive cancer care facilities in North America.
Their respective Radiation Medicine Programs, which encompass the Departments of Radiation Therapy, Radiation Oncology and Radiation Physics, boast some of the most advanced technologies and treat a volume and variety of patients that is among the highest on the continent.
Combined, they employ over 60 radiation oncologists, more than 50 radiation physicists and 300 radiation therapists, many who are internationally known for their work in radiation medicine.
Both facilities are well equipped to support modern 3D radiation treatment planning with Pinnacle treatment planning terminals, high-energy photon and electron radiation treatment, total body irradiation, stereotactic radiation therapy and radiosurgery, conformal, intensity-modulated and image-guided radiation therapy, and LDR and HDR brachytherapy.
Our department is also affiliated with several U of T Teaching Hospitals located in the Toronto area.
The OCC, a comprehensive cancer program at the Sunnybrook Health Sciences Centre (SHSC), is one of the largest cancer treatment and research facilities in North America.
OCC operates programs in:
The Princess Margaret is the largest cancer treatment and research facility in Canada and one of the largest in North America.
The PM operates programs in:
Our multidisciplinary practice approach and patient-centred care philosophies create the opportunity to define the future best practices in medicine.
Dr. David Jaffray